Table 1.
Study | Clear aim | Inclusion patients | Collection data | Appropriate end points | Assessment end points | Follow-up period | Loss to follow-up | Calculation study size | Total |
---|---|---|---|---|---|---|---|---|---|
Trousdale | 1 | 2 | 0 | 2 | 0 | 2 | 1 | 0 | 8 |
Meier | 2 | 2 | 0 | 2 | 0 | 2 | 2 | 0 | 10 |
Price | 2 | 2 | 0 | 2 | 0 | 2 | 2 | 0 | 10 |
Van Geenen | 1 | 2 | 0 | 2 | 0 | 2 | 2 | 0 | 10 |
Murase | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 0 | 13 |
Nagy | 2 | 0 | 0 | 2 | 1 | 2 | 2 | 0 | 9 |
Chia | 2 | 2 | 0 | 2 | 0 | 2 | 2 | 0 | 10 |
Miyake | 2 | 2 | 0 | 2 | 1 | 2 | 1 | 0 | 10 |
Kataoka | 2 | 2 | 0 | 2 | 1 | 2 | 2 | 0 | 11 |
Boeckers | 1 | 2 | 0 | 2 | 0 | 1 | 2 | 0 | 8 |
Walenkamp | 2 | 2 | 0 | 2 | 1 | 1 | 0 | 0 | 8 |
The items are scored 0 (not reported), 1 (reported but inadequate) or 2 (reported and adequate).